Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ZJYL stock hub

Jin Medical International Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ZJYLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
16.6M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
ZJYL
In the news

Latest news · ZJYL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/E13.9
P25 14.9P50 23.2P75 38.5
ROE4.8
P25 -105.6P50 -46.5P75 -3.1
ROIC2.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ZJYL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
222
Groups with data
11
Currency
USD
Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001837821
Company name
Jin Medical International Ltd.
Country
China
Country code
US
Cusip
G5140V120
Employees
273
Employees Change
4%
Employees Change Percent
1.49
Enterprise value
$5.9M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Instruments & Supplies
IPO Date
2023-03-28
Isin
KYG5140V1207
Last refreshed
2026-05-10
Market cap
$16.6M
Market cap category
Nano-Cap
Price
$2.12
Price currency
USD
Rev Per Employee
75,777.56x
Sector
Healthcare
Sic
3842
Symbol
ZJYL
Website
https://www.zhjmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
7.18%
EV Earnings
4.93x
EV/EBIT
9.66x
EV/EBITDA
6.9x
EV/Sales
0.28x
FCF yield
-22.46%
P/B ratio
0.56x
P/E ratio
13.93x
P/S ratio
0.8x
PE Ratio3 Y
81.69x
PE Ratio5 Y
145.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
2.94%
EBITDA Margin
4.12%
Gross margin
30.18%
Gross Profit
$6.2M
Gross Profit Growth
-35.04%
Gross Profit Growth Q
11.33%
Gross Profit Growth3 Y
-0.61%
Gross Profit Growth5 Y
2.57%
Net Income
$1.2M
Net Income Growth
-67.59%
Net Income Growth Q
-31.97%
Net Income Growth Years
0%
Net Income Growth3 Y
-23.93%
Net Income Growth5 Y
-11.59%
Pretax Margin
7.71%
Profit Margin
5.76%
Profit Per Employee
$4,364
Profitable Years
5
ROA
0.77
Roa5y
5.42
ROCE
2.06
ROE
4.75
Roe5y
14.43
ROIC
2.79
Roic5y
19.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr1y
-86.87%
Cagr3y
-28.08%
EPS Growth
-67.61
EPS Growth Q
-31.97
EPS Growth Years
0
EPS Growth3 Y
-27.6
EPS Growth5 Y
6.65
OCF Growth3 Y
22.47%
OCF Growth5 Y
3.01%
Revenue Growth
-11.98x
Revenue Growth Q
-16.53x
Revenue Growth Years
0x
Revenue Growth3 Y
2.53x
Revenue Growth5 Y
5.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.42
Assets
$53.4M
Cash
$29.6M
Current Assets
$44.1M
Current Liabilities
$23.8M
Debt
$18.9M
Debt EBITDA
$17.66
Debt Equity
$0.64
Equity
$29.6M
Liabilities
$23.8M
Long Term Assets
$9.2M
Long Term Liabilities
$0
Net Cash
$10.7M
Net Cash By Market Cap
$64.6
Net Cash Growth
-14.82%
Net Debt EBITDA
$-12.59
Net Debt Equity
$-0.36
Tangible Book Value
$28.5M
Tangible Book Value Per Share
$3.65
WACC
21.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.86
Inventory Turnover
2.05
Net Working Capital
$9.6M
Quick ratio
1.53
Working Capital
$20.3M
Working Capital Turnover
$0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-0.05%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-86.85%
200-day SMA
6.15
3Y total return
-62.81%
50-day SMA
2.28
50-day SMA vs 200-day SMA
50under200
All Time High
509.9
All Time High Change
-99.58%
All Time High Date
2023-12-18
All Time Low
1.64
All Time Low Change
29.19%
All Time Low Date
2026-04-02
ATR
0.27
Beta
7.53
Beta1y
1.29
Beta2y
0.88
Ch YTD
-51.82
High
2.22
High52
18
High52 Date
2025-05-12
High52ch
-88.22%
Low
2.09
Low52
1.64
Low52 Date
2026-04-02
Low52ch
29.19%
Ma50ch
-6.94%
Price vs 200-day SMA
-65.55%
RSI
45.86
RSI Monthly
43.49
RSI Weekly
30.88
Sharpe ratio
-1.59x
Sortino ratio
-2.03
Total Return
-0.05%
Tr YTD
-51.82
Tr1m
5.47%
Tr1w
-8.62%
Tr3m
-23.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$608,182
Operating Income Growth
-83.29
Operating Income Growth Q
-3.05
Operating Income Growth3 Y
-34.16
Operating Income Growth5 Y
-23.72
Operating margin
2.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
891,223%
Float Percent
11.39%
Net Borrowing
7,456,982
Shares Institutions
0.33%
Shares Out
7,827,355
Shares Qo Q
0%
Shares Yo Y
0.05%
Short Float
1.69%
Short Ratio
0.53
Short Shares
0.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
$-3.7M
Average Volume
9,344.05x
Bv Per Share
3.79
CAPEX
$-6.6M
Ch1m
5.47
Ch1w
-8.62
Ch1y
-86.85
Ch3m
-23.74
Ch3y
-62.81
Ch6m
-60.62
Change
-3.64%
Change From Open
0.33
Close
2.2
Days Gap
-3.95
Depreciation Amortization
243,403
Dollar Volume
7,468.8
Earnings Date
2025-08-20
Earnings Time
amc
EBIT
$608,182
EBITDA
$851,585
EPS
$0.15
F Score
4
FCF
$-3.7M
FCF EV Yield
-63.44x
FCF Per Share
$-0.48
Financing CF
7,353,245
Fiscal Year End
September
Founded
2,006
Graham Number
3.60093
Graham Upside
69.86
Income Tax
$214,572
Investing CF
-10,791,736
Ipr
-73.5
Iprfo
-73.5
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2025-08-20
Last Report Date
2025-09-30
Last Split Date
2026-03-16
Last Split Type
Reverse
Last10k Filing Date
2026-02-10
Lynch Fair Value
$0.76
Lynch Upside
-64.1
Ma150
3.95
Ma150ch
-46.36%
Ma20
2.19
Ma20ch
-3.28%
Net CF
-674,549
Next Earnings Date
2026-08-19
Open
2.11
Optionable
No
P OCF Ratio
5.72
Position In Range
21.88
Post Close
2.12
Postmarket Change Percent
-4.71
Postmarket Price
$2.02
Ppne
7,980,542
Price Date
2026-05-08
Price EBITDA
$19.49
Ptbv Ratio
0.58
Relative Volume
0.38x
Revenue
20,687,274x
Tax By Revenue
1.04x
Tax Rate
13.45%
Tr6m
-60.62%
Volume
3,523
Z Score
5.27
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ZJYL pay a dividend?

Capital-return profile for this ticker.

Performance

ZJYL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-86.8%
S&P 500 1Y: n/a
3Y total return
-62.8%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ZJYL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Float: +11.4% of shares outstanding
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
+1.7%
0.5 days to cover
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

ZJYL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.9
Neutral momentum band
Price vs 200-day MA
-65.5%
50/200-day relationship not available
Beta (5Y)
7.53
More volatile than the market
Sharpe ratio
-1.59
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ZJYL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ZJYL stock rating?

Jin Medical International Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ZJYL analysis?

The full report lives at /stocks/ZJYL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ZJYL?

The latest report frames ZJYL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ZJYL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.